Safety Results of a Multi-Institutional Phase 1 Clinical Trial of Afatinib in Combination with Docetaxel and Postoperative Radiation Therapy for High-Risk Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Margalit, D. N. [1 ,2 ]
Haddad, R. I. [2 ]
Tishler, R. B. [1 ,2 ]
Chau, N. [3 ]
Schoenfeld, J. D. [1 ,2 ]
Bakst, R. L. [4 ]
Misiukiewicz, K. [4 ]
Goguen, L. [2 ,5 ]
Annino, D. [2 ,5 ]
Mchugh, P. [6 ]
Bacay, A.
Rath, L. [4 ]
Groden, P. [6 ]
Catalano, P. S. [7 ]
Rabinowits, G. [3 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Otolaryngol, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
95
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: Results of Radiation Therapy Oncology Group trial 9615
    Robbins, KT
    Kumar, P
    Harris, J
    McCulloch, T
    Cmelak, A
    Sofferman, R
    Levine, P
    Weisman, R
    Wilson, W
    Weymuller, E
    Fu, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1447 - 1454
  • [42] Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer
    Suwinski, Rafal
    Bankowska-Wozniak, Magdalena
    Majewski, Wojciech
    Idasiak, Adam
    Maciejewski, Adam
    Ziolkowska, Ewa
    Windorbska, Wieslawa
    Skladowski, Krzysztof
    Miszczyk, Leszek
    Maciejewski, Boguslaw
    RADIOTHERAPY AND ONCOLOGY, 2008, 87 (02) : 155 - 163
  • [43] Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma
    Harada, Koji
    Sato, Mitsunobu
    Ueyama, Yoshiya
    Nagayama, Masaru
    Hamakawa, Hiroyuki
    Nagahata, Shunichirou
    Yoshimura, Yasuro
    Osaki, Tokio
    Ryoke, Kazuo
    ANTI-CANCER DRUGS, 2008, 19 (01) : 85 - 90
  • [44] HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell Carcinoma
    Moon, Dominic H.
    Avkshtol, Vladimir
    Vo, Dat
    Ahn, Chul
    Sumer, Baran
    Day, Andrew T.
    Tillman, Brittny
    Myers, Larry
    Truelson, John
    Sher, David J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : 157 - 164
  • [45] Final report of rtog 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck
    Spencer, Sharon A.
    Harris, Jonathan
    Wheeler, Richard H.
    Machtay, Mitchell
    Schultz, Christopher
    Spanos, William
    Rotman, Marvin
    Meredith, Ruby
    Ang, Kie-Kian
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (03): : 281 - 288
  • [46] Inferior Outcomes in Immunosuppressed Patients With High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Surgery and Radiation Therapy
    Manyam, B.
    Saxton, J. P.
    Reddy, C. A.
    Burkey, B. B.
    Scharpf, J.
    Zhang, A. Y.
    Gastman, B.
    Fritz, M. A.
    Vidimos, A. T.
    Koyfman, S. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S764 - S765
  • [47] Inferior Outcomes in Immunosuppressed Patients With High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Surgery and Radiation Therapy
    Manyam, B.
    Saxton, J. P.
    Reddy, C. A.
    Burkey, B. B.
    Scharpf, J.
    Zhang, A. Y.
    Alam, D. S.
    Fritz, M. A.
    Vidimos, A. T.
    Koyfman, S. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 476 - 476
  • [48] Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy
    Manyam, Bindu V.
    Gastman, Brian
    Zhang, Alexandra Y.
    Reddy, Chandana A.
    Burkey, Brian B.
    Scharpf, Joseph
    Alam, Daniel S.
    Fritz, Michael A.
    Vidimos, Allison T.
    Koyfman, Shlomo A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 221 - 227
  • [49] Molecular signatures associated with clinical outcome in patients with high-risk head and neck squamous cell carcinoma treated by surgery and radiation
    Story, Michael D.
    Ang, K. Kian
    Ramdas, Latha
    Giri, Uma
    Ashorn, Cheryl L.
    Naggar, Adel El-K.
    Stivers, David N.
    Coombes, Kevin
    CANCER RESEARCH, 2006, 66 (08)
  • [50] A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma
    Theodoros N. Teknos
    J. Grecula
    A. Agrawal
    M. O. Old
    E. Ozer
    R. Carrau
    S. Kang
    J. Rocco
    D. Blakaj
    V. Diavolitsis
    B. Kumar
    P. Kumar
    Q. Pan
    M. Palettas
    L. Wei
    R. Baiocchi
    P. Savvides
    Investigational New Drugs, 2019, 37 : 702 - 710
12345